John D. Baker, DO

Board-certified Physician
Emergency & Obesity Medicine
Body recomposition = Metabolic optimization

Building

[John D. Baker, DO @DrJDBaker]

Most people think weight loss success = the number on the scale going down.

The research says something more specific: it matters what you're losing.

Lean mass loss increases mortality. Fat mass loss reduces it.

The same 20 pounds lost can have opposite health outcomes. Here's why:

[John D. Baker, DO @DrJDBaker]

New tirzepatide data: 32% lower risk of heart attack, stroke, and death from any cause in type 2 diabetics with excess weight.

The medication that gets called cheating just outperformed decades of traditional PCP advice on the outcomes that actually matter.

Cardiovascular death doesn't grade you on method.

[John D. Baker, DO @DrJDBaker]

Get in shape once. Really once. Learn what your body responds to, what sustainable nutrition actually feels like, what strength training does to your metabolism and your mood.

You cannot unlearn that. The first time is the hardest.

Everything after that is maintenance of something you now know.

[John D. Baker, DO @DrJDBaker]

The best investment you will make this week has no subscription fee, no influencer code, and no monthly cost.

It is an hour of progressive resistance training.

Every system in your body benefits. Your future self has no idea you did it yet.

Do it anyway.

[John D. Baker, DO @DrJDBaker]

A patient on maximum statin therapy with persistent obesity, insulin resistance, and elevated triglycerides still has significant residual cardiovascular risk.

The statin did its job. The job was incomplete because the metabolic dysfunction driving the atherogenic lipid pattern was never addressed. Prescribe the statin. Fix the body composition. Measure ApoB. In that order.

[John D. Baker, DO @DrJDBaker]

Statins lower LDL. That’s what they do well.

What they don’t do: meaningfully reduce ApoB in patients with elevated triglycerides and small dense LDL particles — the atherogenic pattern most common in metabolic dysfunction and obesity.

Treating the lipid panel without treating the metabolic dysfunction driving it is treating the printout, not the patient.

[John D. Baker, DO @DrJDBaker]

The combination that actually addresses cardiovascular lipid risk in obese insulin resistant patients: body recomposition reducing hepatic fat and VLDL output, plus statin therapy for residual LDL-C reduction, plus ApoB as the target rather than LDL-C alone.

Treating one variable in a multi-variable problem produces single variable results.

The cardiovascular risk is not single variable.

[John D. Baker, DO @DrJDBaker]

Building skeletal muscle doesn’t just change how you look.

It improves insulin sensitivity, raises resting metabolic rate, reduces visceral fat, lowers cardiovascular risk, strengthens bone density, preserves cognitive function, buffers against sarcopenia, improves surgical outcomes, predicts cancer survival, and maintains functional independence into old age.

It is the single most productive thing you can do for your long term health. One adaptation. Every system benefits.

[John D. Baker, DO @DrJDBaker]

Body composition and VO2 max are the two most predictive variables for long term health outcomes we can measure.

One tells you what your body is made of. The other tells you how well your engine runs.

Neither is on your standard lab panel. Both are modifiable.

Both matter more than your cholesterol.

[John D. Baker, DO @DrJDBaker]

Retatrutide — GLP-1, GIP, and glucagon triple agonist — is in phase 3 trials with early data showing weight loss approaching bariatric surgery outcomes.

Most patients will never need it. For those with severe obesity and exhausted first-line options it may represent the most significant pharmacological advance in obesity medicine since semaglutide.

The pipeline is not slowing down.

[John D. Baker, DO @DrJDBaker]

Body recomposition = more muscle, less visceral fat.

It improves insulin sensitivity, reduces cardiovascular risk, lowers systemic inflammation, improves hormonal balance, preserves cognitive function, strengthens bone density, and predicts functional independence into old age.

It is not a fitness goal. It is the most evidence-backed intervention in metabolic medicine.

Remember, the scale will not show you any of that.

[John D. Baker, DO @DrJDBaker]

Obesity is associated with 13 cancers, cardiovascular disease, type 2 diabetes, dementia, and early death.

The medical system’s primary response for the last 50 years was ‘eat less, move more.’

We meant well. We were not helpful.

[John D. Baker, DO @DrJDBaker]

The tools now exist to break the cycle.

GLP-1 medications that restore satiety signaling. Physician-guided protocols that address body composition, not just weight.

Objective data that replaces guesswork with a clinical picture.

You are not a bad person for struggling with obesity. You are a person who deserves treatment that matches the complexity of the disease.

That treatment exists. Find a physician who understands it.

[John D. Baker, DO @DrJDBaker]

Obesity is associated with type 2 diabetes, cardiovascular disease, hypertension, sleep apnea, MASH, sarcopenia, and at least 13 obesity-related cancers.

This is not a moral indictment. It is a disease burden with a mechanism and increasingly, with effective treatments.

The conversation needs to separate the biology from the blame.

[John D. Baker, DO @DrJDBaker]

None of that makes you a bad person. Obesity is a chronic disease with documented neurological, hormonal, and metabolic pathology.

The patient struggling with weight is not failing.

They are fighting a broken feedback loop with tools that were never designed to fix it.

[John D. Baker, DO @DrJDBaker]

Muscle mass predicts who survives cancer, who recovers from illness, and who stays functionally independent into old age.

It is the single most important tissue in the human body for long term health outcomes.

We are not focused on it nearly enough.

[John D. Baker, DO @DrJDBaker]

Fix the body composition first. Reduce visceral fat. Build skeletal muscle. Restore insulin sensitivity.

The inflammatory burden drops. The metabolic dysfunction improves.

At that point red light therapy and cold exposure may add marginal benefit on top of a solid foundation. But the foundation is not optional.

You cannot supplement, biohack, or cold plunge your way past poor body composition. The sequence matters.

[John D. Baker, DO @DrJDBaker]

Red light therapy. Cold plunge. Anti-inflammatory diet.

These are the interventions dominating the wellness conversation right now.

They are also rounding errors if your body composition is poor.

You cannot biohack your way out of visceral adiposity. The fundamentals are not optional prerequisites. They are what actually improves health outcomes.

[John D. Baker, DO @DrJDBaker]

Visceral fat is an active endocrine organ secreting inflammatory cytokines, free fatty acids, and ceramides that drive systemic inflammation 24 hours a day.

No cold plunge frequency or red light panel wattage overcomes that signal.

The source of the inflammation is the adipose tissue. Addressing the downstream effects while leaving the source intact is not a health strategy. It makes no sense.